Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study
The Journal of Infectious Diseases · 2026
DOI: 10.1093/infdis/jiaf615 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Infectious Diseases, 2026. Verfasst von Anabella Clara Fantilli und 23 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Ciencias Médicas, Instituto de Virología "Dr. J.M. Vanella", Universidad Nacional de Córdoba, Córdoba, Argentina. Hauptthemen laut MEDLINE: Hepatitis E, Hepatitis E virus, Liver Diseases. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European-Latin American ESCALON, European Union Horizon, Ministry of Science, Technology and Innovation of Argentina.
Abstract (Originalsprache)
Background
Hepatitis E virus (HEV) is a major cause of acute hepatitis worldwide, yet its impact in Latin America remains underexplored. Evidence suggests that chronic liver disease (CLD) patients infected with HEV face increased risks of disease progression and mortality. The PROGINS haplotype has been proposed to influence susceptibility to HEV. This study assessed HEV infection in CLD patients from Latin America and potential associated factors, including the PROGINS haplotype.
Methods
A total of 971 individuals—784 with CLD and 187 healthy controls (HC)—from six countries (Argentina, Brazil, Chile, Colombia, Ecuador, and Peru) were analyzed for anti-HEV IgG and IgM (ELISA), HEV-RNA (RT-qPCR and nested PCR with Sanger sequencing and phylogenetic analysis), and the PROGINS haplotype (PCR).
Results
The overall anti-HEV IgG seroprevalence was 15.2%: 15.4% in CLD and 14.4% in HC, with no statistical difference. Marked geographical disparities were observed, with Chile showing the highest (45.1%) and Argentina the lowest (4.2%) anti-HEV IgG detection rates. Cirrhosis and alcohol-related liver disease (ALD) were significantly associated with higher detection rates, while neither age nor sex influenced HEV seroprevalences. PROGINS haplotype showed no significant association with HEV infection. Anti-HEV IgM and HEV-RNA were detected in 11.2% and 0.4% of participants, respectively. Phylogenetic analysis confirmed zoonotic HEV-3 circulation in the region.
Conclusions
This first multinational assessment of HEV in Latin America reveals heterogeneous seroprevalence across countries. Findings support considering HEV testing in diagnostic protocols for CLD patients particularly those with cirrhosis or ALD- when presenting with unexplained hepatic decompensation or acute hepatitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Ciencias Médicas, Instituto de Virología "Dr. J.M. Vanella", Universidad Nacional de Córdoba, Córdoba, Argentina.
- Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.
- Departamento de Virología, LACE laboratorios, Córdoba, Argentina.
- Hospital Privado Universitario de Córdoba, Córdoba, Argentina.
- Centro de Enfermedades Hepáticas y Digestivas (CEHYD), Bogotá, Colombia.
- Departamento de Gastroenterología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
ORCID-Profile: Anabella Clara Fantilli, María Belén Pisano, Guadalupe Di Cola, Pablo Romagnoli, Jhon Prieto, Enrique Carrera, Grisel Maribel Britos, María Eugenia Bernaschini, Andre Boonstra, Viviana Elizabeth Ré
Förderung
- European-Latin American ESCALON
- European Union Horizon
- Ministry of Science, Technology and Innovation of Argentina
- NIH HHS
- Secretariat of Science and Technology
- National University of Córdoba
- National Institutes of Health
Zitieren
APA
Fantilli, A. C., Pisano, M. B., Martínez Wassaf, M., Di Cola, G., Balderramo, D., Romagnoli, P., Prieto, J., Arrese, M., Carrera, E., Díaz Ferrer, J., Mattos, A. Z., Fernández, M., Britos, G. M., Bernaschini, M. E., Sepúlveda, S. A., Roa, J. C., Grutadauria, S., Zerega, A., Ferreiro, M., …, & Ré, V. E. (2026). Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf615
Vancouver
Fantilli AC, Pisano MB, Martínez Wassaf M, Di Cola G, Balderramo D, Romagnoli P, et al. Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study. The Journal of Infectious Diseases. 2026. doi:10.1093/infdis/jiaf615
BibTeX
@article{Fantilli2026,
author = {Fantilli, Anabella Clara and Pisano, María Belén and Martínez Wassaf, Maribel and Di Cola, Guadalupe and Balderramo, Domingo and Romagnoli, Pablo and Prieto, Jhon and Arrese, Marco and Carrera, Enrique and Díaz Ferrer, Javier and Mattos, Angelo Z and Fernández, Marina and Britos, Grisel Maribel and Bernaschini, María Eugenia and Sepúlveda, Santiago A and Roa, Juan Carlos and Grutadauria, Sergio and Zerega, Alina and Ferreiro, Melina and González Ballerga, Esteban and Salmon, Jonathan and Boonstra, Andre and Debes, José Daniel and Ré, Viviana Elizabeth},
title = {Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study},
journal = {The Journal of Infectious Diseases},
year = {2026},
doi = {10.1093/infdis/jiaf615}
}
EUVIMED